Starling Oncology to Participate in Wells Fargo Healthcare Conference
Starling Oncology (NASDAQ: STLN) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the Wells Fargo Healthcare Conference in Boston on Tuesday, September 8, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Starling Oncology (NASDAQ: STLN) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the Wells Fargo Healthcare Conference in Boston on Tuesday, September 8, 2026. Their appearance will include a fireside chat scheduled from 4:30–5:05 p.m. ET, with a webcast available via the Investor Relations section of the company’s website.
Details
News Market Reaction – STLN
On Aug 24, the day this news came out, STLN closed 5.18% below the previous close. Our momentum scanner recorded 11 alerts for this stock that day.
Data tracked by StockTitan Argus for the Aug 24 session.
Key Figures
- Conference date
- September 8, 2026
- Wells Fargo Healthcare Conference in Boston
- Fireside chat time
- 4:30–5:05 p.m. ET
- Wells Fargo Healthcare Conference
Historical Context
-
Starling Nexus launch was followed by a negative 24-hour price reaction.
-
Q2 results and raised full-year guidance were followed by a positive price reaction.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the Wells Fargo Healthcare Conference, being held in Boston on Tuesday, September 8, 2026, including a fireside chat from 4:30–5:05 p.m. ET.
A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at https://investors.starlingoncology.com/.
About Starling Oncology, Inc.
Founded in 2007, Starling Oncology, Inc. (Nasdaq: STLN) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Formerly known as The Oncology Institute, Starling Oncology offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 400 employed and network clinicians and over 100 clinics and network locations of care across five states and growing, Starling Oncology is coordinating cancer care for the better. For more information visit www.starlingoncology.com. Please follow us on LinkedIn, X (formerly Twitter), or Bluesky.
Contacts
Media
ICR Healthcare
StarlingPR@icrhealthcare.com
Investors
ICR Healthcare
StarlingIR@icrhealthcare.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.